Novel Drug May Help Repair Failing Hearts
Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure, according to a first-in-man study published today in JACC: Basic to Translational Science.
Heart failure, characterized by a loss of cardiac function, is among the leading causes of death worldwide. A significant portion of heart failure patients, particularly those with severe left ventricular systolic dysfunction, do not sufficiently respond to current medical therapy.
Researchers examined the safety and efficacy of a single infusion of cimaglermin, which acts as a growth factor for the heart, helping the structural, metabolic and contractile elements of the heart to repair itself following injury. The study enrolled 40 heart failure patients who were taking optimal medical therapy for at least three months prior to the trial. Compared to patients who received a placebo, patients who received a high dose of cimaglermin had a sustained increase in left ventricular ejection fraction, or pumping capacity, through 90 days after dosing, with the maximum increase reached at day 28.
“These findings support continued clinical development of the investigational drug cimaglermin, including further safety evaluations and detailing the potential improvement on clinical heart failure outcome measures,” said Daniel J. Lenihan MD, from the division of cardiovascular medicine at Vanderbilt University and the lead author of the study. “As with all experimental therapeutics, additional studies will be required and subject to regulatory review to determine if the relative risks and benefits of cimaglermin warrant approval.”
The most common side effects were headache and nausea, which were temporarily associated with exposure to the drug. One patient receiving the highest planned dose of cimaglermin experienced an adverse reaction that met the stopping criteria of Federal Drug Administration guidance for drug induced liver injury.
Limitations of this study include the small sample size and the fact that patients only received a single infusion rather than multiple doses.
“Although the results of the study must be regarded as provisional because of the small numbers of patients, the results of this study are nonetheless very exciting,” said Douglas L. Mann, MD, FACC, editor-in-chief of JACC: Basic to Translational Science. “Instead of blocking the fundamental mechanisms that lead to cardiac injury, the early results with cimaglermin suggest that it may also be possible to administer therapeutics that allow the failing heart to repair itself using its own repair mechanisms. If the results of this study can be replicated and translated into improvements in clinical outcomes in larger numbers of patients in phase II and III clinical trials, it will represent a paradigm shift in the way in which clinicians treat patients with heart failure.”
Learn more: Novel Drug May Help Repair Failing Hearts
Receive an email update when we add a new HEART FAILURE article.
The Latest on: Restore cardiac function
via Google News
The Latest on: Restore cardiac function
- A loophole in Florida's Wrongful Death Acton October 13, 2019 at 5:25 am
They say surgeons repaired his aneurysm and preserved his heart valve, but despite their best efforts to restore full function to his heart, one section of his left ventricle did not respond to ...
- Tissue Banking Market Size To Exhibit a CAGR of 10.8% By 2026 | Share Analysis, Industry Trends, Future Insights and Growth Opportunitieson October 9, 2019 at 4:56 am
Human cells and tissue transplantation can save lives and/or restore essential functions. For instance, a corneal graft can restore sight in corneal blindness, and transplantation of a human heart ...
- Careful monitoring of children following cardiac surgery may improve long-term outcomeson October 3, 2019 at 7:37 am
In a medical records study covering thousands of children, a U.S.-Canadian team led by researchers at Johns Hopkins Medicine concludes that while surgery to correct congenital heart disease (CHD) ...
- Bernie Sanders’ Doctors Confirm He Had a Heart Attackon October 2, 2019 at 5:41 pm
A 78-year-old man with a medical history of gout and diverticulitis comes to the emergency department after developing chest discomfort while at a work function ... that supply blood to the heart, ...
- Moving beyond hype: Could one-two treatment restore damaged heart muscle?on September 27, 2019 at 10:50 am
Heart attacks can cause ... and so impairs the heart’s pumping function,” says Tim Kamp, a professor of medicine who is co-leader of a new grant designed to attack two roadblocks that have stymied ...
- Researchers Conclude First-Ever Clinical Human Trial Using a Natural Hydrogel to Repair Heart Tissueon September 15, 2019 at 11:45 am
For the first time ever, researchers have successfully conducted an FDA-approved Phase 1 human clinical trial of an injectable hydrogel that aims to repair the damage and restore cardiac function in ...
- Nanotube Fibers Used to Heal Damaged Human Heartson September 12, 2019 at 2:02 am
An irregular heartbeat—or cardiac arrhythmia—is one of the leading causes of sudden death. Now researchers have found a way to repair damaged hearts and restore normal electrical function using carbon ...
- Medical science: Repurposing cancer immunotherapy for heart diseaseon September 11, 2019 at 5:00 pm
Targeted immune cells called CAR T cells are shown to restore heart function in a mouse model of heart injury. More research is needed to determine whether this approach could be translated to the ...
- FDA phase 1 trial shows hydrogel to repair heart is safe to inject in humans -- a firston September 11, 2019 at 4:35 pm
Scientists successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who ...
via Bing News